These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37643325)

  • 1. The Ratio of miR-122 to miR-20a (miR-122/miR-20a) Is a Useful Minimally Invasive Biomarker for Non-Alcoholic Fatty Liver Disease Detection.
    Hattori Y; Yamada H; Munetsuna E; Fujii R; Ando Y; Yamazaki M; Mizuno G; Tsuboi Y; Ishihara Y; Ichino N; Sugimoto K; Osakabe K; Ishikawa H; Ohashi K; Suzuki K
    Genet Test Mol Biomarkers; 2023 Aug; 27(8):239-247. PubMed ID: 37643325
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of circulating miR-20a, miR-27a, and miR-126 with non-alcoholic fatty liver disease in general population.
    Ando Y; Yamazaki M; Yamada H; Munetsuna E; Fujii R; Mizuno G; Ichino N; Osakabe K; Sugimoto K; Ishikawa H; Ohashi K; Teradaira R; Ohta Y; Hamajima N; Hashimoto S; Suzuki K
    Sci Rep; 2019 Dec; 9(1):18856. PubMed ID: 31827150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum miR-29a and miR-122 as Potential Biomarkers for Non-Alcoholic Fatty Liver Disease (NAFLD).
    Jampoka K; Muangpaisarn P; Khongnomnan K; Treeprasertsuk S; Tangkijvanich P; Payungporn S
    Microrna; 2018; 7(3):215-222. PubMed ID: 29848284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
    Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
    PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-20a-5p Ameliorates Non-alcoholic Fatty Liver Disease via Inhibiting the Expression of CD36.
    Wang X; Ma Y; Yang LY; Zhao D
    Front Cell Dev Biol; 2020; 8():596329. PubMed ID: 33344451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients.
    Ye D; Zhang T; Lou G; Xu W; Dong F; Chen G; Liu Y
    Life Sci; 2018 Sep; 208():201-207. PubMed ID: 30030064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.
    Yamada H; Suzuki K; Ichino N; Ando Y; Sawada A; Osakabe K; Sugimoto K; Ohashi K; Teradaira R; Inoue T; Hamajima N; Hashimoto S
    Clin Chim Acta; 2013 Sep; 424():99-103. PubMed ID: 23727030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased brain-derived neurotrophic factor in the serum of persons with nonalcoholic fatty liver disease.
    Hattori Y; Yamada H; Munetsuna E; Ando Y; Mizuno G; Fujii R; Tsuboi Y; Ichino N; Osakabe K; Sugimoto K; Ishikawa H; Ohashi K; Suzuki K
    Endocr J; 2022 Aug; 69(8):999-1006. PubMed ID: 35354697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease.
    Yamada H; Ohashi K; Suzuki K; Munetsuna E; Ando Y; Yamazaki M; Ishikawa H; Ichino N; Teradaira R; Hashimoto S
    Clin Chim Acta; 2015 Jun; 446():267-71. PubMed ID: 25958847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population.
    Liu XL; Pan Q; Zhang RN; Shen F; Yan SY; Sun C; Xu ZJ; Chen YW; Fan JG
    World J Gastroenterol; 2016 Nov; 22(44):9844-9852. PubMed ID: 27956809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Serum miR-1296 may Serve as an Early Biomarker for the Diagnosis of Non-Alcoholic Fatty Liver Disease.
    Yu F; Wang X; Zhao H; Hao Y; Wang W
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study.
    Pereira ENGDS; Paula DP; de Araujo BP; da Fonseca MJM; Diniz MFHS; Daliry A; Griep RH
    World J Gastroenterol; 2021 Aug; 27(29):4913-4928. PubMed ID: 34447235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease.
    Okamoto K; Koda M; Okamoto T; Onoyama T; Miyoshi K; Kishina M; Matono T; Kato J; Tokunaga S; Sugihara T; Hiramatsu A; Hyogo H; Tobita H; Sato S; Kawanaka M; Hara Y; Hino K; Chayama K; Murawaki Y; Isomoto H
    PLoS One; 2020; 15(2):e0219412. PubMed ID: 32106257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives.
    Hochreuter MY; Dall M; Treebak JT; Barrès R
    Mol Metab; 2022 Nov; 65():101581. PubMed ID: 36028120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients.
    Ng L; Sin RW; Cheung DH; Leung WK; Man AT; Lo OS; Law WL; Foo DC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study.
    Harrison SA; Ratziu V; Boursier J; Francque S; Bedossa P; Majd Z; Cordonnier G; Sudrik FB; Darteil R; Liebe R; Magnanensi J; Hajji Y; Brozek J; Roudot A; Staels B; Hum DW; Megnien SJ; Hosmane S; Dam N; Chaumat P; Hanf R; Anstee QM; Sanyal AJ
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):970-985. PubMed ID: 32763196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
    Hu H; Han Y; Cao C; He Y
    J Transl Med; 2022 Sep; 20(1):398. PubMed ID: 36064712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Value and Role of miR-129-5p in Non-Alcoholic Fatty Liver Disease.
    Wang Y; Feng Y; Zhang H; Niu Q; Liang K; Bian C; Li H
    Horm Metab Res; 2021 Oct; 53(10):692-698. PubMed ID: 34528223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease.
    Tan Y; Ge G; Pan T; Wen D; Gan J
    PLoS One; 2014; 9(8):e105192. PubMed ID: 25141008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease.
    Xu Q; Li Y; Shang YF; Wang HL; Yao MX
    World J Gastroenterol; 2015 Jan; 21(2):511-6. PubMed ID: 25593466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.